Litigation Details for Baudax Bio, Inc. (Bankr. E.D. Pa. 2024)
✉ Email this page to a colleague
Baudax Bio, Inc. (Bankr. E.D. Pa. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-02-22 |
| Court | United States Bankruptcy Court, E.D. Pennsylvania | Date Terminated | |
| Cause | Assigned To | Ashely M. Chan | |
| Jury Demand | Referred To | ||
| Patents | 10,471,067; 8,512,727 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Baudax Bio, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Baudax Bio, Inc. (Bankr. E.D. Pa. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-03-07 | 23 | Equity Security Holders AND Schedule A/B - (for first filing and amendments) AND Schedule D - (for first filing and amendments) AND Schedule E/F- (for first filing and amendments) AND Schedule G - (for first filing and amendments) AND Schedule H - (for first filing and amendments) AND Statement of Financial Affairs | 2/21/2017 2017‐0157061 6/8/2017 10,471,067 11/12/2019 TRANSFER … 60. Patents, copyrights, trademarks, and trade secrets Various patents; a list of the…Licenses, franchises, and royalties Various patent agreements and licenses; a list of the… Date Publication # Publication Date Patent # Issue Date Status … Basis for the claim: Licensing and patent fees for BX 1000, 2000 and Date(s) debt | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
